HIV and Vision Loss: CMV Retinitis Risk & Prevention
Untreated or advanced HIV can lead to blindness, primarily through cytomegalovirus (CMV) retinitis—an opportunistic infection that destroys retinal tissue.
HIV depletes CD4+ T cells, impairing immune surveillance. When CD4 counts fall below 50 cells/µL, latent CMV can reactivate, causing necrotizing retinitis. Without treatment, this progresses to retinal detachment and irreversible vision loss.
Prevention & Management:
- Antiretroviral therapy (ART): Effective ART suppresses HIV, restores CD4 counts, and has dramatically reduced CMV retinitis incidence since the HAART era.
- Regular ophthalmologic screening: HIV patients with CD4 < 100 cells/µL should have dilated fundus exams every 3–6 months.
- Prompt treatment: If CMV retinitis is detected, intravitreal ganciclovir/valganciclovir or systemic antivirals can halt progression.
With modern ART and monitoring, blindness from HIV is now rare. Early diagnosis, consistent treatment adherence, and routine eye exams are key to preserving vision.
HIV & AIDS - Related Articles
- Texas HIV Disclosure Laws: Understanding Reporting & Confidentiality
- Substance Abuse & HIV: Understanding the Connection
- HIV-Positive Pregnancy Rights: Legal & Healthcare Protections
- HIV Vaccine Development: Current Status, Challenges & Timeline
- Condom Effectiveness: Limitations and Proper Use Tips
- How HIV Is Transmitted: A Clear Guide
- Runny Nose and HIV: No Direct Link
